NDC 0409-4755-02 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-4755
- Requested NDC
- 0409-4755-02
- Package NDCs from labels
- 0409-4755-18, 0409-4755-03, 0409-4755-02
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-06-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Ondansetron - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
| ONDANSETRON - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Ondansetron - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-03-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Ondansetron - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Ondansetron - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-4755-03 | Ondansetron | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 34 | |
| 0409-4755-18 | Ondansetron | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 34 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-4755-01 | ML - Milliliter | 0409-4755 | 2c7bacb7-8a01-4c6b-bb92-fe3e8a5e19a2 | 1 | 2012-07-24 |
| 0409-4755-02 | ML - Milliliter | 0409-4755 | 4e46e9f5-3b4c-4ffd-bbe8-ed076eb1a685 | 1 | 2012-07-24 |
| 0409-4755-03 | ML - Milliliter | 0409-4755 | 3a992647-f868-4adb-b6ea-71f9865aa617 | 1 | 2012-07-24 |
| 0409-4755-11 | ML - Milliliter | 0409-4755 | efb609dd-6add-4e03-bb7a-a5828c25388b | 1 | 2015-04-03 |
| 0409-4755-12 | ML - Milliliter | 0409-4755 | 04775b37-24f0-4a50-a19b-f16c63c8490d | 1 | 2015-04-03 |
| 0409-4755-18 | ML - Milliliter | 0409-4755 | 3832c8a7-0b4a-4065-be59-c8b2976afa9e | 1 | 2015-04-03 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| ONDANSETRON | ONDANSETRON | Henry Schein, Inc. | 1a44601b-c31c-4779-a688-28cc4cc75e8b | 2026-10-19 | Warnings, Adverse reactions | 1740467 NMH84OZK2B |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 426ba54f-199a-41d1-8c27-f827bea56854 | 2026-10-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | A-S Medication Solutions | 674ea285-8f84-4603-9655-82200c523fe5 | 2026-10-12 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 61758670-91ab-4422-8d9d-e8ca87eecae8 | 2026-10-12 | Warnings, Adverse reactions | 1740467 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 14276805-4e99-4bbe-ad76-ffc06eddb38a | 2026-10-09 | Warnings, Adverse reactions | NMH84OZK2B |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | REMEDYREPACK INC. | 960e2104-18c3-4cfa-abf6-f1b30c452918 | 2026-10-05 | Warnings, Adverse reactions | NMH84OZK2B |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.